Cited by 178Antibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in BacteriaHistorical Medical Research and Treatments

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index; none of the 3 sources its claims cite is checked for support yet.

Amoxycillin: A new Semi-synthetic Penicillin

Open access
Sutherland, R., Croydon, E. A. P., Rolinson, G. N.·1972·BMJ

Abstract

Amoxycillin (alpha-amino-p-hydroxybenzylpenicillin) is a new semi-synthetic penicillin with a broad spectrum of antibacterial activity similar to that of ampicillin. Penicillin-sensitive strains of staphylococci, streptococci, and pneumococci were sensitive to concentrations of 0.1 mug or less of amoxycillin/ml. Strains of Haemophilus influenzae were inhibited by a level of 0.5 mug/ml, and most strains of Escherichia coli, Proteus mirabilis, Shigella sonnei, Salmonella species, and Streptococcus faecalis were sensitive to a concentration of 5 mug or less of amoxycillin/ml. Penicillinase-producing strains of Staphylococcus aureus and strains of Pseudomonas aeruginosa, indole-positive Proteus, Klebsiella, and Enterobacter were insensitive to amoxycillin. The new penicillin was bactericidal in activity, as with other penicillins, and its antibacterial activity was not reduced in the presence of serum. After oral administration to volunteer subjects amoxycillin produced serum concentrations twice as high as those obtained with similar doses of ampicillin, and the penicillin was recovered unchanged in high concentrations in the urine. The absorption of amoxycillin was not greatly influenced by food, and administration of probenecid resulted in increased and more prolonged concentrations of amoxycillin in serum.

Overview

Integrity signals

Registry

Crossref · 10.1136/bmj.3.5817.13

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

23 Own result · 3 Own interpretation · 2 Sources not found · 1 No basis given

Show all 20 claims

  • It may state two separate claims as one. 9
9 of 9
  • The paper relies on this without support.

    In vitro antibacterial activity and serum concentrations of amoxycillin predict its clinical efficacy in treating infections.

    “The properties of amoxycillin suggest this new semi-synthetic penicillin may have clinical advantages over ampicillin.”
  • The paper relies on this without support.

    Pharmacokinetic results from healthy volunteers apply to patients.

    “The properties of amoxycillin suggest this new semi-synthetic penicillin may have clinical advantages over ampicillin.”
  • The paper relies on this without support.

    The in vitro MIC breakpoints used correspond to clinical susceptibility.

    “most strains of E. coli, P. mirabilis, Sh. sonnei, and Salmonella species were sensitive to 5 ,ug or less of amoxycillin/ml.”
    “The properties of amoxycillin suggest this new semi-synthetic penicillin may have clinical advantages over ampicillin.”
  • The paper relies on this without support.

    Ampicillin is an appropriate comparator for assessing clinical advantages of amoxycillin.

    “Results are reported here to compare the antibacterial activities and absorption and excretion in man of amoxycillin and ampicillin.”
    “The properties of amoxycillin suggest this new semi-synthetic penicillin may have clinical advantages over ampicillin.”
4 of 4

Citations

Cites

Show all 5 references

Research works printed but not linked: 3

  1. [2]2. Penicillin Ampicillin Il I on 19 August 2023 by guest. Protected by copyright. http://www.bmj.com/ Br Med J: first published as 10.1136/bmj.3.5817.13 on 1 July 1972. Downloaded from References
  2. [6]6. Long, A. A. W., Nayler, J. H. C., Smith, H., Taylor, T., and Ward, N. (1971). Journal of the Chemical Society, Section C, p. 1920.
  3. [10]10. Sutherland, R., and Rolinson, G. N. (1971). Antimicrobial Agents and Chemotherapy, 1970, p. 411. on 19 August 2023 by guest. Protected by copyright. http://www.bmj.com/ Br Med J: first published as 10.1136/bmj.3.5817.13 on 1 July 1972. Downloaded from

Cited by

Sorted by citations

See all 178

Metadata

Authors
Sutherland, R., Croydon, E. A. P., & Rolinson, G. N.
Affiliations
University of Oxford (GB)
Venue
BMJ
Publisher
BMJ
Published
1972-07-01
Volume
3
Issue
5817
Pages
13-16
ISSN
  • 0007-1447 (ISSN-L)
  • 1468-5833
OpenAlex
W1969572602
Cited by
178
References
5
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 2
FWCI
15.93
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
Keywords
amoxicillin, semisynthetic penicillins, antibacterial activity, bactericidal activity, serum stability, oral bioavailability, urinary excretion, probenecid, drug interactions, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae, ampicillin comparison
MeSH terms
Administration, Oral, Amines, Benzyl Compounds, Enterobacteriaceae, Escherichia coli, Food, Haemophilus influenzae, Humans, Klebsiella, Microbial Sensitivity Tests, Penicillin Resistance, Penicillins, Phenols, Probenecid, Proteus, Pseudomonas, Salmonella, Shigella sonnei, Staphylococcus, Streptococcus, Enterococcus faecalis, Streptococcus pneumoniae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amoxycillin: A new Semi-synthetic Penicillin. https://app.cochat.ai/papers/10.1136/bmj.3.5817.13
The paper
Sutherland, R., Croydon, E. A. P., & Rolinson, G. N. (1972). Amoxycillin: A new Semi-synthetic Penicillin. BMJ. https://doi.org/10.1136/bmj.3.5817.13